Peptides & the FDA review: your questions, answered

BPC-157 is not an FDA-approved drug and is not a lawful dietary ingredient. It was placed in Category 2 of the interim 503A compounding list in September 2023, then removed from that category in April 2026 and referred to an advisory committee. As of July 2026, no final rule has placed it on the approved 503A bulks list, so it has no cleared legal pathway for compounding.^{1 2 3}

No. Peppies is an independent private venture and is not affiliated with, endorsed by, or acting on behalf of the FDA or any government body.

No. Peppies does not sell, promote, or facilitate the sale of any peptide, and makes no money from their sale. It's an independent education and advocacy resource. Read our full position on the About page.

Peppies is building toward being America's first trusted peptides brand - a consumer brand grounded in independent, cited education rather than sales. It does not currently sell peptides and won't until it's legal to.

Peppies is an independent, fully-cited education resource on therapeutic peptides and the U.S. FDA pharmacy-compounding review. It explains what each peptide is, what the research shows, and where it stands with regulators - with every claim linked to a primary source.